![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 Subunit of Neuronal Nicotinic Receptors
Departments of Molecular & Cellular Pharmacology (B.H., K.B.M., S.E.R., D.E., A.H.M., C.W.L.) and Biochemistry & Molecular Biology (A.M.), Miller School of Medicine, University of Miami, Miami, Florida
We have shown previously that the function of neuronal nicotinic acetylcholine receptors can be modulated by zinc. This modulation varies from potentiation to inhibition, depending on receptor subunit composition and zinc concentration, with the
4
2 and
4
4 receptors displaying the most dramatic potentiation. In this study, we used site-directed mutagenesis to identify glutamate 59 and histidine 162 on the rat
4 subunit as potential mediators of zinc potentiation. By modeling the extracellular domain of the receptor pentamer, we locate these residues to two subunit-subunit interfaces that alternate with the two acetylcholine-binding interfaces. Substitution of a cysteine at either position allows additional reduction of zinc potentiation upon treatment with the methanethiosulfonate reagents N-biotinoylaminoethyl methanethiosulfonate (MTSEA-biotin) and [2-(trimethylammonium)ethyl] methanethiosulfonate. Mutagenesis and methanethiosulfonate treatment are most effective at position 162, and the presence of zinc hinders the reaction of MTSEA-biotin with the substituted cysteine at this position, suggesting that
4His162 participates in forming a coordination site for zinc. Mutagenesis and methanethiosulfonate treatment are less effective at position 59, suggesting that whereas
4Glu59 may be near the zinc coordination site, it may not be participating in coordination of the zinc ion. It is noteworthy that the position of
4Glu59 within the neuronal nAChR is identical to that of a residue that lines the benzodiazepine-binding site on GABAA receptors. We suggest that the zinc potentiation sites on neuronal nAChRs are structurally and functionally similar to the benzodiazepine-binding sites on GABAA receptors.
Address correspondence to: Dr. Charles W. Luetje, Molecular and Cellular Pharmacology, R-189, University of Miami, P.O. Box 016189, Miami, FL 33101. E-mail: cluetje{at}chroma.med.miami.edu
This article has been cited by other articles:
![]() |
T.-Y. Wu, C. M. Smith, S. M. Sine, and M. M. Levandoski Morantel Allosterically Enhances Channel Gating of Neuronal Nicotinic Acetylcholine {alpha}3{beta}2 Receptors Mol. Pharmacol., August 1, 2008; 74(2): 466 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation J. Neurosci., July 2, 2008; 28(27): 6884 - 6894. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hsiao, K. B. Mihalak, K. L. Magleby, and C. W. Luetje Zinc Potentiates Neuronal Nicotinic Receptors by Increasing Burst Duration J Neurophysiol, February 1, 2008; 99(2): 999 - 1007. [Abstract] [Full Text] [PDF] |
||||